The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the patient will experience a recurrence years after their initial diagnosis. Now, ...

An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving ...

A novel prognostic staging system predicted survival for patients with breast cancer after neoadjuvant chemotherapy (NACT), addressing an unmet need, researchers reported. One of the benefits of ...

Small cell lung cancer (SCLC) staging helps doctors determine how advanced the cancer is and choose the best treatment approach. Doctors typically classify SCLC into two stages: limited, where cancer ...

A new study has developed a novel framework to classify breast cancer based on the intricate steps of the cancer-immunity cycle (CIC), potentially ...

[18F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer Prognostic staging after neoadjuvant chemotherapy (NACT) is not ...

Vulvar cancer is staged based on the extent it has spread. During the early stage, the cancer remains in the vulva. In its most advanced stage, the cancer has spread to distant organs and tissue.